Rapport Therapeutics Inc.... (RAPP)
Rapport Therapeutics Common Stock Max Pain By Strike
RAPP trades at $14.66, 2.3% below the near-term max pain of $15 expiring Sep 19, 2025 (34 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($2.5-$15), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Rapport Therapeutics Common Stock Max Pain By Expiry
Max pain for RAPP shows an upward trend from 2.5 to 15, suggesting bullish positioning in longer-dated options. The 154% spread signals divergent expectations across timeframes. Most levels below 14.66 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 15 | 0.34 (2.32%) |
| Oct 17, 2025 | 12.5 | -2.16 (-14.73%) |
| Nov 21, 2025 | 2.5 | -12.16 (-82.95%) |
| Feb 20, 2026 | 2.5 | -12.16 (-82.95%) |